News
Lupin Transfers Two Oncology Drug Candidates to Kaveri Therapeutics
Kaveri will advance Lupin’s two oncology drug candidates through global clinical trials.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Kaveri will advance Lupin’s two oncology drug candidates through global clinical trials.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
